Table 3.
Estimates of prevalence, intraclass correlation coefficients, their respective 95% CI, design effect and mean cluster size for variables related to outcome
Variable | P (%) | ICC | 95% CI for ICC | DEFF | na |
---|---|---|---|---|---|
· Any hemorrhagic complication |
24.8 |
0.165 |
0.062−0.268 |
129.54 |
354 |
· Abruptio placentae |
5.7 |
0.016 |
0.003−0.029 |
9.55 |
354 |
· Placenta previa/acreta |
2.2 |
0.017 |
0.004−0.031 |
6.24 |
354 |
· Complicated ectopic pregnancy |
3.1 |
0.034 |
0.009−0.059 |
17.72 |
354 |
· Uterine rupture |
0.3 |
0.005 |
<0.001−0.011 |
2.12 |
354 |
· Severe post abortion hemorrhage |
1.3 |
0.015 |
0.003−0.028 |
5.92 |
354 |
· Postpartum hemorrhage |
12.5 |
0.248 |
0.110−0.387 |
200.97 |
354 |
✓ Atony |
63.0 |
0.375 |
0.134−0.617 |
77.37 |
44 |
✓ Retained placenta |
11.8 |
0.114 |
0.005−0.224 |
12.94 |
44 |
✓ Tears |
8.8 |
0.130 |
0.008−0.251 |
10.04 |
44 |
✓ Coagulopathy |
4.6 |
0.102 |
0.002−0.203 |
13.51 |
44 |
✓ Uterine inversion |
0.6 |
0.035 |
<0.001−0.079 |
1.65 |
44 |
✓ Other obstetric cause |
11.2 |
0.370 |
0.130−0.610 |
43.77 |
44 |
· Other severe hemorrhage |
1.0 |
0.023 |
0.005−0.041 |
6.16 |
354 |
· Any complication due to hypertension |
70.2 |
0.183 |
0.072−0.294 |
124.72 |
354 |
· Severe preeclampsia |
51.2 |
0.231 |
0.099−0.363 |
188.23 |
354 |
· Eclampsia |
4.5 |
0.023 |
0.005−0.040 |
14.62 |
354 |
· Severe hypertension |
18.3 |
0.334 |
0.169−0.499 |
289.00 |
354 |
· HELLP syndrome |
6.2 |
0.028 |
0.007−0.049 |
15.43 |
354 |
· Acute fatty liver |
0.2 |
0.005 |
0.001−0.010 |
1.59 |
354 |
· Any other complication |
17.2 |
0.103 |
0.034−0.172 |
31.93 |
354 |
· Pulmonary edema |
1.7 |
0.020 |
0.004−0.036 |
4.45 |
354 |
· Seizures |
1.4 |
0.009 |
0.001−0.016 |
3.66 |
354 |
· Thrombocytopenia |
3.9 |
0.022 |
0.005−0.039 |
6.77 |
354 |
· Thyrotoxic crises |
0.1 |
0.007 |
0.001−0.013 |
1.55 |
354 |
· Shock |
3.1 |
0.034 |
0.009−0.059 |
9.95 |
354 |
· Acute respiratory failure |
4.0 |
0.051 |
0.014−0.087 |
19.37 |
354 |
· Acidosis |
1.6 |
0.021 |
0.005−0.038 |
12.54 |
354 |
· Cardiopathy |
1.7 |
0.013 |
0.002−0.023 |
5.71 |
354 |
· Stroke |
0.2 |
0.001 |
0.001−0.003 |
1.10 |
354 |
· Coagulation defects |
2.0 |
0.012 |
0.002−0.021 |
4.69 |
354 |
· Disseminated intravascular coagulation |
0.6 |
0.012 |
0.002−0.021 |
2.60 |
354 |
· Thromboembolism |
0.9 |
0.010 |
0.001−0.018 |
4.95 |
354 |
· Diabetic ketoacidosis |
0.2 |
0.004 |
0.001−0.008 |
0.94 |
354 |
· Jaundice/liver dysfunction |
1.4 |
0.014 |
0.003−0.026 |
2.46 |
354 |
· Meningitis |
<0.1 |
<0.001 |
0.001−0.002 |
0.94 |
354 |
· Severe sepsis |
3.5 |
0.064 |
0.019−0.109 |
18.09 |
354 |
✓ Postpartum endometritis |
19.5 |
0.131 |
0.011−0.252 |
3.95 |
13 |
✓ Post abortion endometritis |
11.0 |
0.043 |
0.001−0.115 |
2.13 |
13 |
✓ Pulmonary focus |
29.3 |
0.055 |
0.001−0.133 |
2.03 |
13 |
✓ Urinary focus |
25.0 |
0.013 |
0.001−0.067 |
1.08 |
13 |
✓Other |
15.2 |
0.042 |
0.001−0.113 |
1.15 |
13 |
· Acute renal failure |
2.2 |
0.027 |
0.006−0.047 |
8.68 |
354 |
· Complication possibly associated with Influenza A ‘H1N1’ |
2.2 |
0.056 |
0.016−0.097 |
20.62 |
354 |
· Any clinical maternal near miss criteria |
5.5 |
0.037 |
0.010−0.065 |
15.44 |
354 |
· Cyanosis |
1.3 |
0.023 |
0.005−0.040 |
12.63 |
354 |
· Gasping |
0.4 |
0.009 |
0.001−0.017 |
4.21 |
354 |
· Respiratory rate <6 or RR>40 |
2.0 |
0.016 |
0.003−0.029 |
8.42 |
354 |
· Shock |
2.6 |
0.031 |
0.008−0.054 |
9.24 |
354 |
· Oliguria unresponsive to fluids or diuretics |
0.9 |
0.010 |
0.001−0.018 |
4.43 |
354 |
· Coagulation problems |
1.0 |
0.012 |
0.002−0.021 |
4.88 |
354 |
· Loss of consciousness for 12h or more |
0.7 |
0.005 |
<0.001−0.010 |
4.25 |
354 |
· Absence of consciousness and absence of pulse rate/heartbeat |
0.7 |
0.006 |
0.001−0.011 |
4.96 |
354 |
· Stroke |
0.3 |
0.002 |
0.001−0.005 |
1.16 |
354 |
· Uncontrolled seizures – total paralysis |
0.2 |
0.001 |
<0.001−0.004 |
2.22 |
354 |
· Jaundice in presence of preeclampsia |
0.3 |
0.001 |
<0.001−0.002 |
1.36 |
354 |
· Any laboratory near miss criteria |
5.2 |
0.047 |
0.013−0.082 |
12.08 |
354 |
· O2 saturation < 90% for longer than 60 min |
1.9 |
0.016 |
0.003−0.029 |
8.30 |
354 |
· PaO2/FiO2 < 200 (Yes/No) |
1.1 |
0.015 |
0.003−0.028 |
8.37 |
354 |
· Creatinine ≥ 300 mmol/l or ≥ 3.5 mg/dl |
1.0 |
0.007 |
0.001−0.013 |
3.03 |
354 |
· Bilirubin ≥ 100 mmol/l or ≥ 6 mg/dl |
0.5 |
<0.001 |
<0.001−0.002 |
1.25 |
354 |
· pH < 7.1 |
0.8 |
0.009 |
0.001−0.016 |
5.32 |
354 |
· Lactate > 5 |
0.8 |
0.098 |
0.032−0.165 |
18.31 |
354 |
· Platelet < 50,000 |
2.1 |
0.025 |
0.006−0.044 |
5.32 |
354 |
· Absence of consciousness plus glucose and ketoacids in urine |
0.2 |
0.004 |
<0.001−0.009 |
3.49 |
354 |
· Condition of woman at discharge (Medical discharge) |
94.1 |
0.011 |
0.002–0.020 |
6.54 |
354 |
· Unsafe abortion |
0.6 |
0.025 |
0.006–0.045 |
7.43 |
310 |
· Maternal Death |
1.5 |
0.018 |
0.004−0.033 |
7.93 |
354 |
· Maternal Death + NM | 9.5 | 0.077 | 0.023−0.130 | 21.09 | 354 |
P: Prevalence of each category; ICC: Intraclass Correlation Coefficient; 95% CI: 95% confidence interval; DEFF: Design effect; na: Mean cluster size; NM: Near miss.